Clinical Study of the Efficiency and Safety of Afala in Patients with Benign Prostatic Hyperplasia

K. V. Savel’eva,M. V. Kachanova,V. N. Pavlov,R. A. Kazikhinurov,M. Yu. Frolov, A. B. Mukhin,V. V. Udut, Z. A. Yurmazov,Yu. L. Dugina,S. A. Sergeeva,O. I. Epshtein

Bulletin of Experimental Biology and Medicine（2009）

引用 0|浏览23

暂无评分

摘要

The use of afala in patients with benign prostatic hyperplasia and moderate urination disturbances reduced the symptoms of the disease, improved urodynamic parameters, and increased quality of life. Clinical efficiency of afala was comparable with the efficiency of Serenoa repens extract (reference preparation).

查看译文

关键词

benign prostatic hyperplasia,prostate-specific antigen,ultralow doses

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要